Ottimo Pharma has officially launched, with backing from Medicxi and the appointment of an exceptional management team. ? Read the full press release ?? www.ottimopharma.com ? #OttimoPharma #Biotech #Pharma #CancerResearch #Immunotherapy
Ottimo Pharma
生物技术研究
Pioneering bi-functional medicines to extend the lives of people living with cancer
关于我们
Ottimo Pharma is a private biotechnology company, co-founded in 2020 by Medicxi and Jonny Finlay, focused on the development of pioneering innovative cancer therapies for solid tumors. The Company's lead program, Jankistomig, is a PD1-VEGFR2 bi-functional antibody designed to target both immune checkpoint inhibition and angiogenesis in a single IgG therapy. By advancing this dual-pathway approach, Ottimo Pharma aims to improve cancer treatment outcomes and reduce overall healthcare burden. The Company boasts a world-class leadership team, including David Epstein as Chair and CEO, Mehdi Shahidi as Head of Development and CMO, and James Sabry as Vice-Chair of the Board. Ottimo Pharma anticipates filing an IND in late 2025.
- 网站
-
ottimopharma.com
Ottimo Pharma的外部链接
- 所属行业
- 生物技术研究
- 规模
- 2-10 人
- 类型
- 私人持股
- 创立
- 2020
Ottimo Pharma员工
动态
-
?? Exciting news from Ottimo Pharma! ?? We have officially launched, with backing from Medicxi and the appointment of an exceptional management team. Leading the charge is David Epstein, who joins as Chair and Chief Executive Officer. He is joined by Mehdi Shahidi, Ottimo’s Head of Development and Chief Medical Officer, and James Sabry, who joins as Vice-Chair of the Board. Ottimo is focused on advancing Jankistomig, our groundbreaking PD1/VEGFR2 bi-functional antibody designed to change the face of cancer immunotherapy by targeting both immune checkpoint inhibition and angiogenesis. With this innovative approach, we aim to deliver new hope to patients with solid tumors. Preclinical work is already underway, and we expect to enter the clinic in 2025. Make sure you’re following Ottimo Pharma on LinkedIn to stay up to date as we work to bring this game-changing therapy to patients! ?? For more details, read the full press release linked in the comments below. #OttimoPharma #Biotech #Pharma #CancerResearch #Immunotherapy
-